Filing Details
- Accession Number:
- 0000929638-24-003214
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-24 16:01:08
- Reporting Period:
- 2024-09-20
- Accepted Time:
- 2024-09-24 16:01:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1133869 | Capricor Therapeutics Inc. | CAPR | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1361865 | Nippon Shinyaku Co Ltd | 14 Nishinosho Monguchi Cho Kisshoin Minamiku Kyoto M0 00000 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Acquisiton | 2024-09-20 | 2,798,507 | $5.36 | 7,090,351 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On September 20, 2024, Capricor Therapeutics, Inc., a Delaware corporation (the "Issuer") issued 2,798,507 shares of common stock, $0.001 par value per share (the "Common Stock") to Nippon Shinyaku Co Ltd (the "Reporting Person"), acquired in a private placement pursuant to the terms and conditions of a Subscription Agreement, dated as of September 16, 2024, between the Reporting Person and the Issuer.